Clinical Trial Update: Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating budesonide as prophylaxis to prevent engraftment syndrome after hematopoietic cell transplantation and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Engraftment Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Henry Ford Health System | Conditions: Engraftment Syndrome | Phase 3 | Status: RECRUITING